Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis.

Literature DB >> 27151126

Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis.

Brigid S Boland^1,2, Preet Bagi², Mark A Valasek³, John T Chang^1,2,4, Ranier Bustamante⁴, Lisa Madlensky⁵, William J Sandborn^1,2, Olivier Harismendy^1,6, Samir Gupta^1,4,6.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2016 PMID： 27151126 PMCID： PMC5824983 DOI： 10.1038/ajg.2016.92

Source DB: PubMed Journal: Am J Gastroenterol ISSN： 0002-9270 Impact factor: 10.864

× No keyword cloud information.

4 in total

1. Successful treatment of Cronkhite-Canada syndrome using anti-tumor necrosis factor antibody therapy.

Authors: Daisuke Watanabe; Makoto Ooi; Namiko Hoshi; Michitaka Kohashi; Tomoo Yoshie; Nobunao Ikehara; Masaru Yoshida; Emmy Yanagita; Takashi Yamasaki; Tomoo Itoh; Takeshi Azuma
Journal: Endoscopy Date: 2014-10-14 Impact factor: 10.093

2. Cronkhite-Canada syndrome associated with schizophrenia.

Authors: Masaharu Nakayama; Hiromi Muta; Shinichi Somada; Toyoki Maeda; Toshitaka Mutoh; Kanako Shimizu; Yoko Suehiro; Terumasa Hisano; Ryo Kurita; Takeshi Shiraishi; Masaki Mori; Yasuji Yoshikawa; Nobuto Tsunetomi; Akihiro Uchida; Kenzaburo Tani
Journal: Intern Med Date: 2007-02-15 Impact factor: 1.271

3. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis.

Authors: A Kurimasa; H Ouyang; L J Dong; S Wang; X Li; C Cordon-Cardo; D J Chen; G C Li
Journal: Proc Natl Acad Sci U S A Date: 1999-02-16 Impact factor: 11.205

4. PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.

Authors: Anne-Laure Mathieu; Estelle Verronese; Gillian I Rice; Fanny Fouyssac; Yves Bertrand; Capucine Picard; Marie Chansel; Jolan E Walter; Luigi D Notarangelo; Manish J Butte; Kari Christine Nadeau; Krisztian Csomos; David J Chen; Karin Chen; Ana Delgado; Chantal Rigal; Christine Bardin; Catharina Schuetz; Despina Moshous; Héloïse Reumaux; François Plenat; Alice Phan; Marie-Thérèse Zabot; Brigitte Balme; Sébastien Viel; Jacques Bienvenu; Pierre Cochat; Mirjam van der Burg; Christophe Caux; E Helen Kemp; Isabelle Rouvet; Christophe Malcus; Jean-Francois Méritet; Annick Lim; Yanick J Crow; Nicole Fabien; Christine Ménétrier-Caux; Jean-Pierre De Villartay; Thierry Walzer; Alexandre Belot
Journal: J Allergy Clin Immunol Date: 2015-04-02 Impact factor: 10.793

4 in total

6 in total

Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis.

1. Successful treatment of Cronkhite-Canada syndrome using anti-tumor necrosis factor antibody therapy.

2. Cronkhite-Canada syndrome associated with schizophrenia.

3. Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis.

4. PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.

1. Cronkhite-Canada syndrome complicated with three malignant tumors: a case report and whole exome sequencing analysis.

2. Cronkhite-Canada syndrome associated with perianal condyloma acuminatum with malignant transformation: A case report.

3. Exome analysis for Cronkhite-Canada syndrome: A case report.

4. Cronkhite-Canada Syndrome: A Rare Cause of Chronic Diarrhea.

5. The Long-Term Clinical and Endoscopic Outcomes of Cronkhite-Canada Syndrome.

6. A Successful Steroid-Sparing Approach in Cronkhite-Canada Syndrome.